Trial NCT03432676

View at ClinicalTrials.gov 
Org. Study IDs: 2016-0893
Secondary IDs: 2016-0893 NCI-2018-00912 P30CA016672

Last trial update was posted on 2019-05-30

MeSH Interventions

Pembrolizumab

MeSH Conditions

Pancreatic Neoplasms

Other Conditions

ATM Gene Mutation Deleterious BRCA1 Gene Mutation Deleterious BRCA2 Gene Mutation Homologous Recombination Deficiency Pancreatic Ductal Adenocarcinoma Stage II Pancreatic Cancer AJCC v8 Stage IIA Pancreatic Cancer AJCC v8 Stage IIB Pancreatic Cancer AJCC v8 Stage III Pancreatic Cancer AJCC v8 Stage IV Pancreatic Cancer AJCC v8

Stopping Reasons

Incyte (supporter of the study) is no longer going to support the study.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID